Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins
- Written by The Bulletin
.
More Articles ...
- OPPO and Discovery Channel Bring Global Celebration Moments to Life on the World Day for Cultural Diversity
- 2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies
- VinFuture 2025: 1,705 nominations worldwide – twelvefold increase in nominating partners over five seasons
- TDCX Founder and CEO, Laurent Junique, named Businessman of the Year; launches new venture to help enterprises navigate complexity and unlock full potential of AI
- COOFANDY Marks 10th Anniversary with Dual Silver Awards at Berlin and New York Product Design Competitions
- Zeagoo Women’s Jackets Win Silver at the 2025 Berlin Design Awards
- Southeast Asia Navigates U.S. Tariffs: An Octa Broker Analysis
- BlueOnion and Morningstar Sustainalytics Collaborate to Expand Sustainable Investment and Due Diligence Coverage
- Uni-Bio Science Group Receives NMPA Approval for 金因康® (Diquafosol Sodium Eye Drops), Advancing Dry Eye Syndrome Treatment in China
- Europe’s Largest Inaugural Tech and Startup Event Opens in Berlin as the Continent Spurs Momentum for Open Innovation and AI Leadership
